Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Instem (INS) Ord 10p

Sell:350.00p Buy:370.00p 0 Change: No change
Market closed Prices as at close on 11 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:350.00p
Buy:370.00p
Change: No change
Market closed Prices as at close on 11 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:350.00p
Buy:370.00p
Change: No change
Market closed Prices as at close on 11 October 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Share news, reports & tips

  • Instem profits climb as outsourced services revenue jumps

    23 September 2019 11:12

    (Sharecast News) - Instem on Monday reported a jump in interim profits after booking double-digit revenue growth on the back of higher outsourced services and software as a service (SaaS) orders.

  • Instem trades in line as SEND revenues more than double

    15 July 2019 11:17

    (Sharecast News) - IT solutions group Instem told investors on Monday that its full-year performance looked set to be in line with expectations after witnessing SEND (the Standard for the Exchange of...

  • Instem\'s profits soar on recurring revenue growth

    1 April 2019 08:49

    (Sharecast News) - Instem, the IT provider to the early development healthcare market, reported solid annual profit growth as experienced a \"growing shift\" towards recurring revenues.

  • Instem climbs after 500% increase in SEND order value

    22 January 2019 11:30

    (Sharecast News) - Instem rose on Tuesday after it reported that it finished the year in line with expectations following a 500% increase in total order values received for its SEND software.

  • Instem breaks even after jump in orders

    24 September 2018 08:13

    (Sharecast News) - Life sciences software company Instem saw its shares climb on Monday after swinging to a first-half profit on the back of impressive order growth.

  • Instem on track as SEND platform drives success

    23 July 2018 08:24

    (Sharecast News) - Instem on Monday reported that trading in the first six months of the year was in line with expectations after an increase in orders and several new client wins.

  • Instem wins contract with Fortune 500 player

    6 June 2018 09:23

    (Sharecast News) - Life science IT solutions provider Instem boasted on Wednesday that a large Fortune 500 pharmaceuticals company has adopted its Samarind RMS software-as-a-service (SaaS) solution in a...

  • Instem nets contract extension amid release of strong 2017 results

    26 March 2018 10:39

    (ShareCast News) - Drug research and development company Instem announced on Monday that it has secured a significant contract extension from a company using its SEND platform.

  • Instem flags potential after converting large customer to SaaS model

    7 March 2018 09:47

    (ShareCast News) - Instem, a provider of IT solutions to the life sciences market, has signed up "one of the world's largest" chemical companies to its software-as-a-service product suite,...

  • Instem faces setback at year end

    16 January 2017 10:52

    (ShareCast News) - Instem, an AIM-listed provider of IT solutions to the global early development healthcare market, reported a "strong" performance for the year ended 31 December 2016 but faced...

  • Instem appoints new COO

    9 January 2017 15:31

    (ShareCast News) - Instem, a provider of IT solutions to the global early development healthcare market, has appointed MaryBeth Thompson as chief operating officer with immediate effect.

  • Instem's full year results to be behind expectations, shares plunge

    21 November 2016 10:10

    (ShareCast News) - Shares in Instem plunged on Monday after the healthcare computer services company warned full year results would be behind expectations as its clinical business had "further...

Company announcements Announcements


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.

© Digital Look Ltd 1998-2019. All rights reserved.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.